News May 23, 2011
How does one control and modify the self-assembly process of organic molecules towards a desired solid state? Andreas Lemmerer, Joel Bernstein and Volker Kahlenberg ask themselves this very question in their recent CrystEngComm Hot Article.
Isoniazid is an active pharmaceutical ingredient that helped cure tuberculosis as part of a triple therapy cocktail. It co-crystallizes with carboxylic acids to form pharmaceutical co-crystals and is also a versatile supramolecular reagent as it has multiple donor and accepting groups to interact with different functional groups. Find out more about this study and Isoniazid in the article – FREE to read until 31 May 2011.
Reproduced by permission from The Royal Society of Chemistry from CrystEngComm Blog at http://blogs.rsc.org/ce/
Ingestible Drug-Delivery Materials May Improve Patient Treatment ComplianceNews
Hydrogel-based capsules could expand and reside in the GI tract for days, slowly releasing medication.READ MORE
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Large-Scale Production of Living Brain Cells Enables Entirely New ResearchNews
After performing a biopsy on the patient, the skin cells are transformed into brain cells that effectively imitate the disease and the age of the patient.READ MORE
Comments | 0 ADD COMMENT
International Conference and Exhibition on Nanomedicine and Nanotechnology
Nov 23 - Nov 24, 2017